Voyager Therapeutics (VYGR) Net Margin (2015 - 2026)
Voyager Therapeutics (VYGR) reported Net Margin of 1077.4% for Q1 2026, down 59816.0% on a YoY basis from N/an in Q1 2025, and down 503.95% sequentially from 178.39% in Q4 2025.
Voyager Therapeutics (VYGR) Net Margin (2015 - 2026) Analysis & Trends
Voyager Therapeutics (VYGR) has 12 years of Net Margin data on file, last reported at 1077.4% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 59816.0% year-over-year to 1077.4%; the trailing twelve-month figure through Mar 2026 stood at 319.27% (down 19283.0% YoY), and the FY2025 full-year result was 296.53%, down 21528.0% from the prior year.
- Net Margin declined to 1077.4% in Q1 2026, from 178.39% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 1524.26% in Q4 2022 to a low of 3239.97% in Q1 2022.
- A 5-year average of 499.13% and a median of 208.69% in 2025 frame the typical range for Net Margin.
- Across the five-year window, Net Margin sank 189616 bps in 2022 and jumped 332240 bps in 2023, its largest moves.
- Tracing VYGR's Net Margin over 5 years: stood at 1524.26% in 2022, then tumbled by 96 bps to 62.59% in 2023, then slumped by 975 bps to 547.33% in 2024, then jumped by 67 bps to 178.39% in 2025, then slumped by 504 bps to 1077.4% in 2026.
- Business Quant data shows VYGR's Net Margin at 1077.4% in Q1 2026, 178.39% in Q4 2025, and 208.69% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - | -1,077.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,077.40% |
| Dec 31, 2025 | -178.39% |
| Sep 30, 2025 | -208.69% |
| Jun 30, 2025 | -641.96% |
| Mar 31, 2025 | -479.24% |
| Dec 31, 2024 | -547.33% |
| Sep 30, 2024 | -36.72% |
| Jun 30, 2024 | -34.29% |
| Mar 31, 2024 | -58.10% |
| Dec 31, 2023 | 62.59% |
| Sep 30, 2023 | -561.36% |
| Jun 30, 2023 | -453.22% |
| Mar 31, 2023 | 82.43% |
| Dec 31, 2022 | 1,524.26% |
| Sep 30, 2022 | 42.90% |
| Jun 30, 2022 | -2,680.76% |
| Mar 31, 2022 | -3,239.97% |
| Dec 31, 2021 | 20.34% |
| Sep 30, 2021 | -1,696.15% |
| Jun 30, 2021 | -3,147.68% |